Home
The XCell-Center is a private clinic group and institute for regenerative medicine located in Düsseldorf and Cologne, Germany. Bringing together therapeutical use of autologous adult stem cells and medical research, it is our mission to:- Provide therapeutic application of autologous adult stem cells to patients at the highest medical standard;
- Extend existing knowledge on the effects of autologous adult stem cells by supporting pre-clinical and clinical research.
We offer patients with degenerative diseases the opportunity to undergo an innovative and promising stem cell treatment.
Since the start in January 2007, more than 1600 patients have safely undergone our various stem cell treatments.
Therapeutic use
The XCell-Center treats patients with their own autologous adult stem cells. It is the first private institute worldwide to hold an official license for the extraction and approval of stem cell material for autologous treatment.
Therapy focuses on the treatment of diabetes mellitus (types 1 and 2 as well as sequelae) and stroke. Further indications comprise neurological diseases, in particular spinal injuries, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Parkinson's and Alzheimer's disease as well as arthritis, heart disease, eye disease, neuropathy and incontinence.
Clinical data
Beside therapeutic applications that take place at the institute, the XCell-Center also spearheads research on the medical use of adult stem cells. Two phase II studies are submitted and are scheduled to start in the second half of 2008.